GAZYVA(R) Vials (1,000 mg/40 ml)

Similar documents
RITUXAN(R) Vials (100 mg/10 ml)

RITUXAN(R) Vials (100 mg/10 ml)

XOLAIR(R) Vials (150 mg)

XOLAIR(R) PFS (150 mg)

TECENTRIQ Vials (1,200 mg/20 ml)

LUCENTIS(R) Vials (0.5 mg/0.05 ml)

HERCEPTIN HYLECTATM Vials (600 mg/5 ml) SC

RITUXAN HYCELATM Vials (1,400 mg/23,400 Units per 11.7 ml)

ACTEMRA(R) Sterile Concentrate for Injection (80 mg)

ACTEMRA(R) Sterile Concentrate for Injection (400 mg)

HERCEPTIN(R) Vials (150 mg)

AVASTIN(R) Vials (400 mg)

CATHFLO ACTIVASE(R) Vials (2 mg)

PEGASYS(R) Prefilled Syringe (180 mcg/0.5 ml)

Trastuzumab Relevant identified uses of the substance or mixture and uses advised against

ACTIVASE Vials (100 mg)

XOFLUZATM (Baloxavir Marboxil) Tablets 20mg

ROFERON-A PFS 3 M IU/0.5 ml

ANEXATE Ampoules 0.5 mg/5 ml

NeoRecormon PFS IU/0.6 ml

NeoRecormon PFS 2000 IU/0.3 ml

TAMIFLU(R) Capsules (75 mg)

HERCEPTIN Vials 60 mg

Interferon alfa-2a Solution

ESBRIET(R) Capsules (267 mg)

TAMIFLU(R) Capsules (75 mg)

PEGASYS(R) Vials (0.135 mg/ml)

DORMICUM Ampoules 5 mg/5 ml

KLONOPIN(R) Tablets (2 mg)

LEXOTAN Tablets 3 mg

KLONOPIN(R) Tablets (2.0 mg)

VALCYTE(R) Powder for Constitution

ESBRIET F.C. Tablets 801 mg

DILATREND Tablets 6.25 mg

LEXOTAN Capsules 1.5 mg

: CER-PCMO. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

FUZEON Vials 90 mg Relevant identified uses of the substance or mixture and uses advised against

COPEGUS(R) F.C. Tablets (200 mg)

SAFETY DATA SHEET. Calcium acetate Ref.50274/1.1/REG_EU/EN Revision Date: Previous date: Print Date:

INVIRASE(R) Capsules (200 mg)

SAFETY DATA SHEET according to 29 CFR and GHS

DORMICUM F.C. Tablets 15 mg

ROACCUTANE Capsules 40 mg

Safety Data Sheet Rapicide PA Part B (RTU) Revision Date: Sourethweg PC HEERLEN The Netherlands TEL

ROACCUTANE Capsules 10 mg

Recommended Use: Pond Dye/Colorant Address: 4385 E 110 th, Grant, MI USA Emergency Telephone:

MATERIAL SAFETY DATA SHEET

: PC BP. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. Product identifier. Cat. No.

Revision Date 6-May-2015 Version 1 1. PRODUCT AND COMPANY IDENTIFICATION. Foremost 3343A Fast Dry Fissure & Crack Filler, Part A

SAFETY DATA SHEET SYNTON PAO 40

Safety Data Sheet SIALON

SECTION 1. Identification of the substance/mixture and of the company/undertaking

SAFETY DATA SHEET. PC35: Washing and cleaning products (including solvent based products). This product has no classification under CHIP.

Safety Data Sheet Cleaning Solution

1. PRODUCT AND COMPANY IDENTIFICATION. F-2372-ES Tortilla Release. INFOTRAC (International) (North America)

MATERIAL SAFETY DATA SHEET

SAFETY DATA SHEET UltraLite Radiator Coolant Leak Tracer Dye Revision Date: May 7, 2015 Version: 3.1 Supersedes: February 12, 2013

: Generic Wood Polish

SAFETY DATA SHEET. Identification of the substance/mixture and of the company/undertaking. Hazards identification

TARCEVA(R) Tablets (25 mg)

CHEMTREC SECTION 2: HAZARDS IDENTIFICATION. 2.1 Classification of Substance or Mixture Classification (GHS-US) Not Classified

ANAPROX(R) Tablets (550 mg)

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking 1.1 Product Identifier

SECTION 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING SECTION 2. HAZARDS IDENTIFICATION

: CHRYSO Fluid Optima 258 EMX

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING. Telephone: +44 (0)

Oseltamivir phosphate

: E3 EXPANDER - Chemical Application Formula

MATERIAL SAFETY DATA SHEET

Francotyp-Postalia GmbH Material Safety Data Sheet. according to ANSI Z Sealit. Print date : Page 1 of 5

Revision Date 23-Nov IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING.

Safety Data Sheet according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations Date of issue: 0429/2015

Plasmid DNA (samples for Nature s dice)

: Calcium Magnesium Citrate

TRANSBRITE FoamFREE Safety Data Sheet

1. Product And Company Identification

LORANN OILS, INC Aurelius Road Office (800) Lansing, MI Fax (517)

LORANN OILS, INC Aurelius Road Office (800) Lansing, MI Fax (517)

Anti-Static Fluid, Document Handler Anti-Static Fluid

: WMC87719-TP1. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

Safety Data Sheet according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations

VALIUM Tablets 10 mg

Issuing Date 10-Sep-2015 Revision Date 18-Aug-2017 Revision Number 4 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Reagent R1A, Reagent R1B, Reagent R2 and Lysis Buffer

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking

SAFETY DATA SHEET Nano-Clear VV-200 Surface Treatment

XELODA(R) Tablets (500 mg)

1. PRODUCT AND COMPANY IDENTIFICATION. Foremost 6004-ES Odor Baggers Vanilla Crème

- VALCYTE Powder for Oral Solution 50 mg/ml

SAFETY DATA SHEET Issuing Date 31 May 2017 Revision Date 27 June 2017 Version 2.3

Safety Data Sheet. Section 1 - Product and Company Identification

SAFETY DATA SHEET. 1/7 Revision Date:

SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 2. HAZARDS IDENTIFICATION. Page 1 / 6

Issuing Date 10-Sep-2015 Revision Date 15-Aug-2016 Revision Number 1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

SAFETY DATA SHEET CLEANLINE DE-IONISED WATER

SAFETY DATA SHEET. Issuing Date 25-Mar-2015 Revision Date 25-Mar-2015 Revision Number 2

Safety Data Sheet. Membrane press adhesive. Note: Specific chemical identities and/or exact percentages have been withheld as a trade secret.

Transcription:

Safety Data Sheet GAZYVA(R) Vials (1,000 mg/40 ml) SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code Synonyms GAZYVA(R) Vials (1,000 mg/40 ml) SAP-10144955 - GA101 liquid product in vials 1.2. Relevant identified uses of the substance or mixture and uses advised against Use - pharmaceutical active substance (antineoplastic) *1 1.3. Details of the supplier of the safety data sheet Company information Enquiries: Genentech, Inc. 1 DNA Way South San Francisco USA-CA 94080 United States of America Phone 001-(650) 225-1000 E-Mail info.sds@roche.com US Chemtrec phone: (800)-424-9300 Local representation: 1.4. Emergency telephone number Emergency telephone number US Chemtrec phone: (800)-424-9300 SECTION 2: Hazards identification Classification of the substance or mixture / Label elements GHS Classification no classification and labelling according to GHS Other hazards Page: 1/6

SECTION 3: Composition/information on ingredients Characterization Ingredients CAS: 949142-50-1 and other inactive ingredients Concentration ~ 2 % SECTION 4: First aid measures 4.1. Description of first aid measures Eye contact Skin contact Inhalation - rinse immediately with tap water for 10 minutes - open eyelids forcibly - remove immediately contaminated clothes, wash affected skin with water and soap - do not use any solvents - remove the casualty to fresh air and keep him/her calm - in the event of symptoms get medical treatment 4.2. Most important symptoms and effects, both acute and delayed 4.3. Indication of any immediate medical attention and special treatment needed to physician - treat symptomatically SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media Flash point (liquid) - adapt extinguishing media to surrounding fire conditions not applicable 5.2. Special hazards arising from the substance or mixture Specific hazards - no particular hazards known 5.3. Advice for firefighters Protection of fire-fighters - precipitate gases/vapours/mists with water spray Page: 2/6

SECTION 6: Accidental release measures 6.1. Personal precautions, protective equipment and emergency procedures Personal precautions - ensure adequate ventilation 6.2. Environmental precautions Environmental protection - no special environmental precautions required 6.3. Methods and material for containment and cleaning up Methods for cleaning up - rinse with plenty of water SECTION 7: Handling and storage 7.1. Precautions for safe handling Suitable materials - glass - do not shake the solution 7.2. Conditions for safe storage, including any incompatibilities Storage conditions - 2-8 C - protected from light - do not freeze Validity Packaging materials - 36 months, 2 to 8 C, see expiry date on the label, after opening the content should be used within a short period - keep it in the outer carton in order to protect from light - glass vials, colourless SECTION 8: Exposure controls/personal protection 8.1. Control parameters Threshold value (Roche) air - IOEL (Internal Occupational Exposure Limit): 0.01 mg/m3 *1 8.2. Exposure controls Respiratory protection Hand protection - Respiratory protection is recommended as a precaution to minimize exposure. Effective engineering controls are considered to be the primary means to control worker exposure. Respiratory protection should not substitute for feasible engineering controls. - respiratory protection not necessary during normal operations - protective gloves (eg made of neoprene, nitrile or butyl rubber) Page: 3/6

Eye protection - safety glasses SECTION 9: Physical and chemical properties 9.1. Information on basic physical and chemical properties Color Form colorless to slightly brownish sterile liquid 9.2. Other information SECTION 10: Stability and reactivity 10.1. Reactivity 10.2. Chemical stability Stability - stable under the conditions mentioned in chapter 7 - does not contain any antimicrobial preservative; therefore, care must be taken to ensure the sterility of the prepared solution 10.3. Possibility of hazardous reactions 10.4. Conditions to avoid Conditions to avoid - warming - shaking 10.5. Incompatible materials 10.6. Hazardous decomposition products Page: 4/6

SECTION 11: Toxicological information 11.1. Information on toxicological effects Sensitization - after parenteral application rare cases of hypersensitivity, including anaphylactic shock, can occur Subchronic toxicity - NOAEL 30 mg/kg/w (i.v., cynomolgus monkey; 13 weeks) *1 Potential Health Effects - Exposure: Inhalation, Ingestion, Skin contact, Eye contact - Carcinogenicity: formulation not listed by NTP, IARC or OSHA SECTION 12: Ecological information 12.1. Toxicity Ecotoxicity - monoclonal antibodies are proteins with highly specific affinity to a certain antigen; therefore, no appreciable ecotoxic potential is to be expected *1 12.2. Persistence and degradability Ready biodegradability - globular proteins are generally well biodegradable *1 12.3. Bioaccumulative potential 12.4. Mobility in soil 12.5. Results of PBT and vpvb assessment 12.6. Other adverse effects Page: 5/6

SECTION 13: Disposal considerations 13.1. Waste treatment methods Waste from residues - observe local/national regulations regarding waste disposal SECTION 14: Transport information - not classified by transport regulations, proper shipping name non-regulated SECTION 15: Regulatory information 15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture TSCA Status Reporting Requirements - FDA Exemption - not on inventory - The United States Environmental Protection Agency (USEPA) has not established a Reportable Quantity (RQ) for releases of this material. - In New Jersey, report all releases which are likely to endanger the public health, harm the environment or cause a complaint to the NJDEPE Hotline (1-609-292-5560) and to local officials. - State and local regulations vary and may impose additional reporting requirements. SECTION 16: Other information Edition documentation - changes from previous version in sections 2, 7, 10 The information in this safety data sheet is based on current scientific knowledge. It should not be taken as expressing or implying any warranty concerning product characteristics. Page: 6/6